Investigators recruited men presenting with urethral discharge syndrome at clinics in Kampala between July 2020 and August 2023. The cohort totaled 411 participants; the median age was 25 years (IQR 22–32), and 16.7% (67/401) reported living with HIV. By nucleic acid amplification test (NAAT) and/or culture, 273 participants (66.4%) were positive for urogenital Neisseria gonorrhoeae. Pharyngeal infection was detected in 29 participants (7.1%) by NAAT and/or culture. Among those with urogenital infection, 10.6% (29/273) were NAAT-positive for pharyngeal gonorrhea—and 20 of those 29 were culture-positive at the pharynx.
The study team reported paired sampling from the penile-meatal site and the pharynx. Culture recovery for pharyngeal NG was lower than NAAT detection, as shown by the fact that not all NAAT-positive pharyngeal samples yielded isolates. The abstract does not specify the exact culture yield percentage for all samples beyond the numbers above, nor does it list detailed culture conditions in the abstract, so those procedural details are not reported here.
Forty NG isolates underwent in vitro susceptibility testing. All 40 isolates were reported as susceptible to cefixime and ceftriaxone. At the same time, the isolates displayed intermediate resistance or resistance to ciprofloxacin, penicillin, and tetracycline. The study team identified eight isolates with high-level resistance to azithromycin. These findings indicate a mixed susceptibility profile: retained susceptibility to extended-spectrum cephalosporins in vitro, coupled with widespread resistance to older agents and macrolide concern in a subset of isolates.
The abstract does not provide MIC distributions, the specific breakpoints used to define susceptibility or resistance, or treatment outcome data. Those technical parameters are not described in the abstract, and therefore are not extrapolated here.
Paired isolates from urethral and pharyngeal sites were subjected to whole genome sequencing (WGS). The study team reported that, among participants with paired WGS data, 52.6% (10 of 19) had different strains at the two anatomical sites. The phylogenetic analysis included 40 isolates and is summarized in the paper’s maximum-likelihood tree, which depicts strain relationships across penile and pharyngeal samples.
The authors observed complex within-host strain diversity in some individuals; the abstract highlights examples of participants infected with multiple strains, including one participant with two different strains belonging to the same multilocus sequence type and another participant infected with three strains. The report does not list the full MLST distribution for all isolates in the abstract, so readers should consult the full text for comprehensive genomic typing tables and sequence data deposited by the authors.
The study team analyzed demographic and behavioral correlates of pharyngeal and urogenital infection and of strain discordance between sites. Men who self-reported engaging in transactional sex were more likely to have different strains at the two anatomical sites; the reported P value for this association was .019. The abstract does not present multivariable model outputs or adjusted effect estimates in the summary, so the association is reported here as documented by the authors without additional modeling detail.
Other behavioral or demographic correlates beyond age, HIV status, and transactional sex are not detailed in the abstract; the full manuscript likely includes expanded analyses, but those specifics are not included in the abstract text and are therefore not reported here.
The investigators concluded that the pharynx is an important reservoir for NG and a site where antimicrobial resistance can emerge. Given the observed differences in strain types between anatomical sites in over half of paired WGS samples, the authors recommended routine pharyngeal testing and pharyngeal susceptibility testing as part of surveillance efforts. They argued that those measures are necessary because reliance on urogenital testing alone may miss pharyngeal infections and within-host diversity that could fuel AMR spread.
Limitations noted or implied by the abstract include absence of detailed MIC data and breakpoints, lack of treatment outcome reporting in the abstract, and limited description of full demographic stratifications beyond median age and HIV prevalence. The abstract did not provide explicit culture methodology parameters or the exact proportion of NAAT-positive pharyngeal samples that failed to culture aside from the counts provided. Those methodological and outcome details would need to be reviewed in the full text or supplemental materials for operational implementation or to inform clinical guidelines.
Unanswered questions remaining from the abstract include whether pharyngeal colonization in this cohort led to treatment failure in practice, the transmission dynamics between pharyngeal and urogenital strains at the population level, and how pharyngeal-specific resistance evolves under different antibiotic exposures. The authors’ data support targeted expansion of pharyngeal surveillance, but precise programmatic steps—including laboratory protocols, breakpoint standards used for MIC interpretation, and clinical treatment outcomes—are not specified in the abstract and require consultation of the full article for implementation details.